Hilary D. Marston
| |
|---|---|
Hilary D. Marston
| |
| Alma mater | Yale College (BA) University of Pennsylvania (MD) Harvard University (MPH) [1] |
| Scientific career | |
| Fields | Global health, pandemic preparedness |
| Institutions | Food and Drug Administration |
Hilary D. Marston is an American physician-scientist and global health policy advisor specializing in pandemic preparedness. She is the Chief Medical Officer of the Food and Drug Administration.
Marston worked for McKinsey & Company and at the Bill & Melinda Gates Foundation as a program officer and special assistant. She then studied internal medicineatBrigham and Women's Hospital.[2] In 2013, Marston joined National Institute of Allergy and Infectious Diseases (NIAID). She has experience in outbreak response, including Zika virus and Ebola.[3] Marston served as a medical officer and policy advisor for global health and pandemic preparedness at NIAID.[4] On April 15, 2020, Marston was the inaugural speaker at the NIH Intramural Research Program's new COVID-19 scientific interest group. Her presentation was titled "The Biomedical Research Response to COVID-19: A View from NIAID."[3] In 2022, Marston joined the US Food and Drug Administration as Chief Medical Officer.[5] She succeeded Janet Woodcock.[5]
This article incorporates text from this source, which is in the public domain.
This article incorporates text from this source, which is in the public domain.
This article incorporates public domain material from websites or documents of the National Institutes of Health.
| International |
|
|---|---|
| National |
|
| Academics |
|
